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I M M U N O L O G Y
Adipose tissue parasite sequestration drives leptin 
production in mice and correlates with human  
cerebral malaria
Pedro Mejia1*†, J. Humberto Treviño-Villarreal1*†‡, Mariana De Niz2,3,4§, Elamaran Meibalan4, 
Alban Longchamp1,5,6, Justin S. Reynolds1, Lindsey B. Turnbull7, Robert O. Opoka8, 
Christian Roussilhon9, Tobias Spielmann10, C. Keith Ozaki5, Volker T. Heussler3, Karl B. Seydel11, 
Terrie E. Taylor11, Chandy C. John7, Danny A. Milner4,12, Matthias Marti2,4, James R. Mitchell1||
Circulating levels of the adipokine leptin are linked to neuropathology in experimental cerebral malaria (ECM), 
but its source and regulation mechanism remain unknown. Here, we show that sequestration of infected red 
blood cells (iRBCs) in white adipose tissue (WAT) microvasculature increased local vascular permeability and 
leptin production. Mice infected with parasite strains that fail to sequester in WAT displayed reduced leptin pro-
duction and protection from ECM. WAT sequestration and leptin induction were lost in CD36KO mice; however, 
ECM susceptibility revealed sexual dimorphism. Adipocyte leptin was regulated by the mechanistic target of 
rapamycin complex 1 (mTORC1) and blocked by rapamycin. In humans, although Plasmodium falciparum infec-
tion did not increase circulating leptin levels, iRBC sequestration, tissue leptin production, and mTORC1 activity 
were positively correlated with CM in pediatric postmortem WAT. These data identify WAT sequestration as a 
trigger for leptin production with potential implications for pathogenesis of malaria infection, prognosis, and 
treatment.
INTRODUCTION
Cerebral malaria (CM) is a life-threatening complication of infection 
with Plasmodium falciparum parasites manifesting with intracerebral 
hemorrhages, brain edema, coma, and death (1–3). Children under 
the age of 5 with little or no previous exposure to P. falciparum in-
fection are most vulnerable to CM (4), but it is currently impossible 
to predict which infected patients will progress to CM (5). Once the 
deadly syndrome has developed, no efficient treatment exists to reduce 
mortality and long-term neurologic disabilities even after successful 
elimination of circulating blood-stage parasites with antimalarial 
chemotherapy. While exact molecular mechanisms remain unclear, 
the disease appears to be the result of a complex interplay between 
infected red blood cells (iRBCs) and local and systemic host immune 
responses (6–8). On a histological level, neurovascular perturbations 
include increased blood-brain barrier (BBB) permeability, leukocyte 
infiltration, platelet activation (9), and dysregulation of the coagula-
tion system in brain endothelium (2, 10).
Sequestration of iRBCs via cytoadherence to the microvasculature 
is a hallmark of severe malaria across multiple Plasmodium species 
(11). iRBC sequestration, which represents a strategy by the parasite 
to evade host immune clearance by the spleen, can lead to pathology 
via endothelial cell activation and/or mechanical obstruction of blood 
flow. In humans, sequestration in the brain microvasculature is a 
defining feature of CM neuropathogenesis (12, 13); but sequestra-
tion also occurs widely in organs and tissues outside of the brain. 
Histopathological analyses of iRBC sequestration in postmortem 
samples from P. falciparum–infected children who died from CM 
or other causes (2, 14–16) show that iRBCs sequester across most of 
the organs analyzed, including the gastrointestinal tract and the 
subcutaneous white adipose tissue (ScWAT) (2, 15, 16). iRBCs ex-
press adhesion molecules including the variable P. falciparum erythro-
cyte membrane protein 1 (PfEMP1) (17, 18) that cytoadhere to host 
endothelial cell receptors such as intercellular adhesion molecule–1 
(ICAM-1), endothelial protein C receptor (EPCR), and the scavenger 
receptor/fatty acid transporter CD36 (19–21). In brain endothelium, 
ICAM-1 is activated by local or systemic proinflammatory cytokines 
(22), while CD36 is expressed in both endothelial and parenchymal 
cells in other tissues with high levels of fatty acid metabolism in-
cluding in WAT and lung, but not in brain (23).
In rodent models of experimental CM (ECM) using Plasmodium 
berghei ANKA (PbA) in susceptible hosts including C57BL/6 mice, 
sequestration of iRBCs also occurs in multiple tissues including lung 
and adipose, both of which are largely dependent on CD36, al-
though the corresponding ligand on PbA-infected RBCs remains to 
be defined (24, 25). Parasites also accumulate in brain, but whether 
this is due to CD36-independent cytoadherence and sequestration 
in the brain microvasculature (26) or the result of BBB dysfunction 
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remains a matter of debate. Despite conservation of sequestration 
in peripheral tissues such as adipose and lung, relevance to ECM 
neuropathology remains questionable in large part because CD36KO 
mice, which fail to support CD36-dependent sequestration in major 
sequestering tissues, still succumb to ECM (11, 24, 25).
In addition to energy storage, adipose tissue and adipocytes are 
metabolically active and capable of secreting a myriad of bioactive 
molecules including cytokines and hormones, collectively known as 
adipokines, which link metabolism, inflammation, and immunity 
(27, 28). One of these adipokines, leptin, has central effects promoting 
food intake and energy expenditure, as well as peripheral effects 
promoting immune and endothelial cell activation (29–31). Leptin 
is increased upon PbA infection and required for ECM neuro-
pathology via induction of T cell effector functions and migration 
capacity (32, 33). Enforced restriction of food intake in the first 3 days 
of blood-stage infection can ameliorate ECM symptoms without 
affecting peripheral parasitemia, in part, by blunting the increase in 
circulating leptin (33). However, neither the trigger for leptin secre-
tion in the ECM model nor the potential role of leptin in CM patho-
genesis in humans has been evaluated.
Here, we tested the hypothesis that iRBC sequestration specifically 
in WAT is a major driver of increased leptin production in ECM. We 
found that leptin protein expression increased in multiple WAT depots 
of wild-type (WT) C57BL/6 mice infected with blood-stage PbA and 
that this correlated with increased vascular permeability in this tis-
sue. Using both parasite and host mutants, we found a correlation 
between iRBC sequestration in WAT and increased host leptin pro-
duction, with the nutrient sensor mechanistic target of rapamycin 
complex 1 (mTORC1) implicated in specific up-regulation of leptin 
mRNA and protein expression in adipocytes. Last, changes in para-
site sequestration, mTORC1 activity, and local leptin expression in 
pediatric postmortem adipose samples from CM patients suggest 
evolutionary conservation of the phenomenon.
RESULTS
Sequestration of iRBCs in WAT promotes tissue vascular 
permeability and leptin production
We evaluated parasite sequestration in different tissues of C57BL/6 
mice over a time course after infection with luciferase-expressing 
PbA (BL6-PbA) parasites (33). Using in vivo imaging, sequestration 
was detectable by day 1 and increased in intensity until day 6, coin-
ciding with the presence of severe neurological symptoms and onset 
of mortality (Fig. 1A). Assessment on day 6 using a more quantitative 
approach in organ extracts following intracardiac perfusion revealed 
that parasite accumulation was highest on a per milligram tissue basis 
in lung, spleen, and WAT, including perigonadal (Pg) and subcuta-
neous depots (Fig. 1B). Together, these tissues accounted for >90% 
of sequestered parasite burden (Fig.  1B). Consistent with in  vivo 
imaging, substantial Pg and ScWAT parasite sequestration were de-
tectable by day 3 and increased at least up to day 6 after infection 
(Fig. 1C). Histological examination of ScWAT of C57BL/6 or ubiquitin 
C (UBC)–green fluorescent protein (GFP) C57BL/6 reporter mice 
on day 6 of infection revealed intravascular localization of iRBCs 
rather than direct contact with adipocytes (Fig. 1D). An absence of 
leukocyte infiltration was also noted in hematoxylin and eosin 
(H&E)–stained sections of this tissue (Fig. 1D). Intravenous injec-
tion of iRBCs harboring mature parasite stages resulted in WAT ac-
cumulation detectable 3 hours after injection into naïve mice (Fig. 1E), 
suggesting that parasite sequestration in this tissue is independent 
of any preexisting local or systemic inflammation.
Circulating leptin increases upon infection and is required for 
full penetrance of neuropathology and mortality in the ECM model 
(33). However, multiple cells secrete this adipokine, and thus, the 
cellular source in the context of ECM is unknown. Because WAT is 
a major source of leptin production, we looked at local leptin ex-
pression by immunofluorescence in WAT sections obtained from 
perfused mice before infection (day 0) and on days 4, 5, and 6 after 
infection. We observed a progressive increase in local leptin expres-
sion in Pg and ScWAT during the course of infection of ECM mice 
(Fig. 1, F and G), with kinetics similar to that of serum leptin (33).
To determine how iRBC sequestration in the WAT vasculature 
could promote leptin production/secretion by adipocytes in the ab-
sence of direct interaction between iRBCs and adipocytes, we exam-
ined vascular permeability over a time course after infection via 
intravenous dextran administration (Fig. 1H). Leakage of dextran 
(70 kDa), indicative of increased vascular permeability in WAT, 
was detected by day 5 of infection. This correlation between WAT 
parasite accumulation and tissue leptin expression suggests WAT as 
a major contributor of circulating leptin and local parasite seques-
tration as the trigger for leptin production.
Sequestration of iRBCs in WAT is required for  
leptin production
To assess the potential role of WAT iRBC sequestration in leptin 
production and correlation with neuropathology, we tested three 
different luciferase-expressing parasites with altered sequestration 
and/or virulence relative to WT PbA parasites. Parasites lacking 
genes encoding the schizont membrane–associated cytoadherence 
(SMAC) protein or skeleton-binding protein 1 (SBP1) exhibit re-
duced peripheral parasitemia levels and CD36-dependent lung and 
WAT sequestration and fail to induce ECM neuropathology (34, 35). 
P. berghei K173 (PbK173) iRBCs also accumulate more slowly and 
fail to induce ECM (36), although sequestration profiles have not 
been reported. We observed reduced peripheral parasitemias with 
PbASBP1, PbASMAC, and PbK173 (Fig. 2, A and B), as well as 
reduced iRBC sequestration on day 6 after infection in PgWAT in 
ScWAT (Fig. 2C). This correlated with significantly reduced iRBC 
accumulation in brain (Fig.  2D), lower levels of serum leptin 
(Fig. 2E), and improved survival (Fig. 2F) relative to C57BL6 mice 
infected with WT PbA. By day 6 after infection, lung sequestration 
was significantly elevated in one parasite line (PbK173) and reduced 
in another (SMAC) and thus failed to correlate with leptin levels 
or survival.
We next tested a model of reduced sequestration due to genetic 
changes in the host. As previously reported (11, 24), female CD36KO 
mice on a C57BL/6 genetic background infected with PbA showed a 
significant reduction in peripheral parasitemia (Fig. 2, A and B) and 
reduced iRBC sequestration in PgWAT, ScWAT, and lung relative 
to WT littermates (Fig. 2C) but still exhibited signs of ECM neuro-
pathology including parasite accumulation in brain on day 6 of 
infection that was not significantly different than control females 
(Fig. 2D). This was likely due to breakdown of BBB function as evi-
denced by increased Evan’s blue staining in brain (Fig. 2G). Mortal-
ity occurred on a similar time frame (days 6 to 10 after infection) 
and with slightly less penetrance than control females, although the 
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The response to PbA infection in male CD36KO mice was very 
similar to female CD36KO mice in terms of reduced peripheral par-
asitemia (Fig. 2, A and B) and reduced sequestration in PgWAT and 
ScWAT with a tendency toward reduction in lung (Fig. 2C). However, 
unlike females, males were almost completely protected against ECM 
neuropathology, including significantly reduced iRBC accumulation 
in brain on day 6 of infection (Fig. 2D), reduced Evan’s blue stain-
ing consistent with maintenance of BBB function (Fig. 2G), and high-
ly significant improvement in survival relative to either WT males 
(which did not significantly differ from WT females in any of the 
abovementioned parameters) or CD36KO females (log-rank test, 
P < 0.0001) (Fig. 2F).
Consistent with our model, reduced WAT sequestration cor-
related with a significant reduction in circulating leptin on day 6 
after infection in both male and female CD36KO mice (Fig.  2E). 
However, sexual dimorphisms in leptin levels before and after in-
fection were also observed. In naïve mice (Fig. 2H, green triangles), 
leptin levels were significantly reduced in female versus male 
CD36KO mice. Furthermore, while leptin levels tended to increase 
upon infection in WT females and males (Fig. 2, H and I), leptin 
levels were significantly reduced upon infection specifically in 
CD36KO males relative to WT males, while in females they re-
mained low.
Together, these data suggest that CD36-dependent sequestration 
of iRBC in WAT, but not lung, underlies the increase in circulating 
leptin levels. They also revealed ECM susceptibility and changes in 
leptin levels upon infection as sexually dimorphic traits in mice 
lacking CD36.
Fig. 1. PbA iRBC sequestration in WAT correlates with leptin production in the ECM model. (A) Time course of luciferase-expressing PbA parasites in live C57BL6 
mice (BL6-PbA) using in vivo imaging from days 1 to 6 after infection. (B) Quantitation of sequestration of luciferase-expressing transgenic PbA parasites in the indicated 
tissue from infected C57BL/6 mice versus naïve controls (n = 3 per group) measured ex vivo in organ homogenates after perfusion on day 6 after infection; Mann-Whitney 
test between groups within a given organ/tissue. (C) Sequestration kinetics of luciferase-expressing PbA parasites in Pg and ScWAT homogenates harvested after per-
fusion on the indicated day after infection (n = 3 per time point; Kruskal-Wallis test with Dunn’s multiple comparisons test on the indicated day versus day 0). (D) Seques-
tration of iRBCs in WAT microvasculature of PbA-infected mice on day 6 after infection by fluorescence microscopy with mCherry-expressing PbA (red to visualize intact 
parasites) in UBC promoter–driven GFP C57BL/6 mice (ubiquitous green expression to visualize host cells) in PgWAT (left) or H&E in ScWAT in WT C57BL/6 mice (right). 
(E) RBCs harboring mature parasites accumulate rapidly in WAT. Sequestration was measured ex vivo in PgWAT homogenates harvested following perfusion 3 hours 
after intravenous injection of saline vehicle (saline) or 5 × 106 iRBCs; n = 4 mice per group; Mann-Whitney test. (F and G) Representative images of leptin expression and 
quantitation of fluorescence intensity in ScWAT (F) and PgWAT (G) of PbA-infected C57BL/6 on days 0, 4, 5, and 6 after infection; n = 10 microscopic fields per mouse 
tissue with two mice per group; Kruskal-Wallis test with Dunn’s multiple comparisons test against day 0. (H) Representative images of FITC-labeled dextran (70 kDa) in 
WAT 2 hours after intravenous injection into mice on the indicated day after infection; quantitation of dextran Fire LUTs (lookup tables) outside of vessel relative to 
day 0 at right; Kruskal-Wallis test with Dunn’s multiple comparisons test against day 0. All data are expressed as mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, and 
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Sequestered iRBCs stimulate adipocyte leptin production 
via cell-autonomous mTORC1 activation
Next, we investigated molecular mechanisms controlling leptin pro-
duction upon parasite sequestration in WAT. The role of the nutrient/
energy sensor mTORC1 in posttranscriptional regulation of leptin 
production in cultured adipocytes has been suggested based on in-
hibition with the macrolide antibiotic rapamycin (37). We thus first 
measured phosphorylation status of the indirect mTORC1 target 
S6 in PgWAT by immunofluorescence across multiple time points 
following infection of C56BL/6 mice with PbA. Increased S6 phos-
phorylation was observed on days 4 to 6 (Fig. 3A). Western blotting 
revealed a similar increase in phosphorylation of the direct mTORC1 
target, S6 kinase (S6K), in WAT from female and male BL6-PbA 
mice on day 6 after infection relative to naïve mice (Fig. 3, B and C). 
This increase in phospho-S6K was mitigated in female WT mice treated 
with rapamycin or infected with PbA-SMAC (Fig. 3B), as well as 
in male CD36KO infected with PbA (Fig. 3C), and thus correlated 
with reduced iRBC WAT sequestration (Fig. 2B).
Treatment of PbA-infected female C57BL6 mice with rapamycin, 
which offered complete protection from ECM-associated mortality 
without affecting peripheral parasitemia, also reduced circulating 
leptin levels (Fig. 3D). To investigate cell-autonomous effects of 
mTORC1 on adipocyte for leptin production, we knocked down the 
mTORC1 inhibitor TSC2  in primary adipocytes using adenoviral 
short hairpin RNA (shRNA). Leptin gene expression and protein 
secretion were both significantly increased in shTSC2-infected adi-
pocytes compared to control cells infected with scrambled shRNA 
construct (Fig. 3E). Expression of adiponectin, an adipokine pro-
duced exclusively by adipocytes, was not affected by shTSC2 infec-
tion. Primary fibroblasts, which do not express adipokines at high 
Fig. 2. Parasite sequestration in WAT is required for systemic leptin production and mortality. (A) Percent peripheral parasitemia over time grouped by experiment 
with corresponding controls as indicated, including SBP1-deficient versus parental WT PbA into WT female BL6 (n = 10 per group), SMAC-deficient versus parental WT PbA 
into WT female BL6 (n = 5 per group), PbK173 versus WT PbA into WT female BL6 (n = 5 to 6 per group), and WT PbA into male or female WT (n = 13 to 16 per group) versus 
male (M) or female (F) CD36KO (n = 16 to 17 per group) BL6 mice. (B) Peripheral parasitemia on day 6 (above) or day 5 (below) expressed as a percent of the corresponding 
sex-matched control. (C to E) Day 6 organ-specific sequestration (C), brain parasite accumulation (D), and serum leptin (E) expressed as a percentage of the control for that 
particular experiment as indicated in (A) and grouped by parasite (top row) or host (bottom row) mutant/strain. Statistics in (B) to (E) were performed using unpaired 
t tests with Welch’s correction or Mann-Whitney tests between mutants/strains and their corresponding host/strain control. (F) Kaplan-Meier survival curves of mice from 
the indicated experimental groups infected on day 0, including the number in each group and the log-rank statistic relative to sex-matched BL6-PbA controls. (G) Evan’s 
blue–stained brains of the indicated sex/genotype on day 6 after infection; white numbers indicate quantification of Evan’s blue after extraction in micrograms per gram 
of tissue. (H and I) Circulating leptin levels of the indicated sex/genotype presented as absolute values before (day 0, green triangles) and on day 6 after infection (red 
triangles), with dotted lines representing individual animals (H) or as differences between circulating leptin on day 6 and day 0 (I); one-way analysis of variance (ANOVA) 
with Sidak’s multiple comparisons tests as indicated. All data are expressed as mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. ns, not significant; d0, 









Mejia et al., Sci. Adv. 2021; 7 : eabe2484     24 March 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 11
levels, were used as negative controls (Fig. 3E). Together, these data 
suggest that mTORC1 activation in adipocytes likely contributes to 
increased leptin expression upon PbA sequestration in WAT.
Parasite sequestration, mTORC1 phosphorylation, and local 
leptin production in human subcutaneous adipose tissue 
correlate with CM mortality without increased 
circulating leptin
To assess the relevance of our findings in the mouse ECM model to 
humans, we explored the relationship between WAT parasite se-
questration, leptin production, and pathology in samples obtained 
from human pediatric CM cases versus controls. We first measured 
plasma leptin levels in CM cases from Cambodia and Senegal versus 
uninfected controls from France and Senegal. Contrary to our re-
sults in mouse models, no significant differences in the levels of cir-
culating leptin were detected among the groups (Fig. 4A). These results 
were confirmed in independent cohorts of well-defined cases of CM 
from Uganda and Malawi versus uninfected, uncomplicated malar-
ia and severe malaria anemia cases (Fig. 4B). We did not find any 
sexual dimorphism in the incidence of CM either in the literature or 
in this dataset.
We next assessed leptin production on a histological level in ScWAT 
from previously characterized fatal CM versus P. falciparum–infected 
non-CM cases from Malawi. As previously reported (2, 15), extensive 
Fig. 3. WAT leptin production is controlled by mTORC1 activity. (A) Representative images of S235/236phospho-S6 expression and quantitation of fluorescence intensity 
in PgWAT of female PbA-infected C57BL/6 on days 0, 4, 5, and 6 after infection; 5 to 10 fields were imaged in at least three sections from two different animals in each 
group; **P < 0.01 and ****P < 0.0001, Kruskal-Wallis test with Dunn’s multiple comparisons test relative to day 0. (B) Immunoblots of total and T389phospho-S6K in PgWAT 
obtained from C57BL/6 female mice that were uninfected (naïve) or from the indicated mouse-parasite experimental group on day 6 after infection or PbA-infected and 
injected with rapamycin (Rap; 1 mg/kg) 2 days earlier, with quantitation below; Mann-Whitney test as indicated. (C) Immunoblots of total and T389phospho S6K in PgWAT 
from male CD36KO and WT littermates infected with PbA with quantitation below; Mann-Whitney test. (D) Serum leptin levels on day 6 after infection (left, Mann-Whitney 
test), survival curves (middle, log-rank test P = 0.0031), and peripheral parasitemia (right) of female BL6-PbA mice treated with vehicle or rapamycin (1 mg/kg) on day 4 
after infection; n = 5 per group. (E) Leptin and adiponectin gene expression and protein secretion into the media in primary adipocyte cultures infected with adenovirus 
expressing shRNAs targeting the mTORC1 inhibitor TSC2 (shTsc2) or control scrambled RNA (shScr) at the indicated multiplicity of infection (MOI). Fibroblasts were used 
as negative controls. NI, not infected; ND, not detected. Kruskal-Wallis test with Dunn’s multiple comparisons test versus NI. All data are expressed as mean ± SD. *P < 0.05, 
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accumulation of P. falciparum iRBCs specifically in ScWAT was de-
tected in CM cases but were virtually absent in non-CM cases (Fig. 4C). 
Leptin levels were then assessed by immunofluorescence staining in 
a subset of P. falciparum–infected non-CM and CM cases, using un-
infected American WAT samples as controls. Notably, leptin expres-
sion in ScWAT, expressed as relative fluorescence intensity, was 
significantly increased in CM cases relative to non-CM and un-
infected controls (Fig. 4D). Consistent with results obtained in mice, 
phosphorylation of the indirect mTORC1 target S6 was significant-
ly elevated in ScWAT from CM cases compared to P. falciparum–
infected non-CM and uninfected controls (Fig. 4E), with substantial 
colocalization of leptin and phospho-S6 in regions of parasite accu-
mulation (Fig. 4F). Together, these results suggest evolutionary 
conservation of a link between Plasmodium-infected RBC seques-
tration in WAT, activation of mTORC1, and increased local leptin 
expression in both humans and mice.
DISCUSSION
Sequestration of Plasmodium-infected RBCs in WAT was first de-
scribed decades ago in humans and nonhuman primates (38). Al-
though Plasmodium species are thought to remain within the adipose 
microvasculature, at least two other parasites—Trypanosoma cruzi, 
the causative agent of Chagas disease, and Trypanosoma brucei, the 
causative agent of African sleeping sickness—localize within and be-
tween adipocytes, respectively, in their mammalian hosts (39). Several 
Fig. 4. Positive correlation between ScWAT parasite sequestration, leptin expression, and mTORC1 activation in human CM. (A and B) Human plasma leptin levels 
measured by ELISA in the following groups: (A) CM cases from Cambodia and Senegal, with uninfected controls (Mal neg) from Senegal or France; (B) CM cases from 
Uganda and Malawi, as well as SMA, uncomplicated malaria (Mal pos) and uninfected controls from Uganda (Mal neg); Kruskal-Wallis test versus uninfected controls. 
(C) Representative differential interference contrast (DIC) image with 4′,6-diamidino-2-phenylindole (DAPI) counterstain of ScWAT from a fatal case of CM. DAPI stains 
endothelial and adipocyte nuclei as well as P. falciparum iRBCs sequestered in the microvasculature; dark hemozoin pigment (arrows) marks iRBCs. Right: Quantification 
of iRBC sequestration in ScWAT sections from fatal CM (n = 24) and P. falciparum–infected non-CM cases (n = 22). Each dot represents the median of the number of iRBCs 
per 10 high-power fields (HPF); Mann-Whitney test. (D) Representative thermal-scale images (magnification, ×10) and quantification of relative intensity of leptin protein 
levels in ScWAT from postmortem P. falciparum–infected non-CM (n = 11) and CM (n = 15) cases relative to uninfected controls (n = 6); Kruskal-Wallis test with Dunn’s 
multiple comparisons tests as indicated. (E) Representative thermal-scale images (magnification, ×20) and quantification of relative intensity of S235/236phospho-S6 pro-
tein levels in ScWAT from uninfected (n = 6), P. falciparum–infected non-CM (n = 11), and CM (n = 15) cases; Mann-Whitney test. (F) Representative confocal microscopy 
images of ScWAT from P. falciparum–infected non-CM and CM cases showing leptin (red), S234/235pS6 (green), parasite [DAPI/DIC and hemozoin (black)], and colocalization 
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potential selective advantages of parasite localization to adipose tis-
sue have been proposed, including ease of transmission, relative 
shelter from the immune system, and/or the presence of abundant 
energy stores during fasting. Nonetheless, the biological significance 
of sequestration in adipose on the host response to parasite infec-
tion, if any, remains unknown.
The major finding here is that CD36-dependent sequestration of 
PbA-infected RBCs in WAT of C57BL/6 mice correlated with an 
increase in the circulating adipokine leptin. In each model tested, 
including three parasite variants that failed to sequester in adipose 
tissue, and in both sexes of CD36KO mice that fail to support adi-
pose sequestration, leptin levels were reduced. The same was not 
true of the other major CD36-dependent sequestering tissue, lung. 
Circulating leptin levels failed to correlate with PbA levels in this 
tissue, although whether the observed luciferase activity represented 
iRBC cytoadherence or accumulation following vascular damage/
occlusion was not addressed in this study. Also relevant is the con-
sistent correlation found between WAT parasite sequestration and 
brain parasite accumulation/sequestration in both experimental and 
human CM, with the specific exception of CD36KO female mice 
(discussed in greater detail below). Combined with our previous 
finding that increased leptin during blood-stage PbA infection in 
mice is required for maximum penetrance of ECM neuropathology 
(33), these data support a model in which sequestration of iRBCs 
specifically in WAT contributes to ECM neuropathology likely through 
effects on vascular and immune activation. While WAT is the larg-
est endocrine organ, where adipocytes are a major source of leptin 
under homeostatic conditions, other cell types can also produce 
leptin, and thus, whether WAT is the sole source of leptin or other 
proinflammatory cytokines relevant to ECM pathology remains a 
limitation of the current study.
Mechanistically, our data point to a role for mTORC1 activation 
in increased leptin expression in WAT in vivo. Treatment with rapa-
mycin, a U.S. Food and Drug Administration (FDA)–approved 
mTORC1 inhibitor, significantly reduced serum leptin levels and 
protected mice from ECM even after a single dose injected late in 
infection. These data are consistent with previous reports showing 
decreased circulating leptin levels upon rapamycin treatment in mice 
and humans (40). While our data in cultured adipocytes supports 
cell-autonomous regulation of leptin expression by mTORC1 signal-
ing, the pleiotropic effects of rapamycin in vivo on T cell migration, 
vascular activation, and parasite sequestration make it difficult to un-
ravel the specific mechanism underlying reduced leptin expression. 
Nonetheless, these findings build on previous reports (33, 41, 42), high-
lighting the therapeutic potential of rapamycin to protect against CM by 
targeting different cell types and inhibiting multiple mechanisms of 
disease.
A further limitation of the study is that we do not know the mech-
anism by which mTORC1 is activated in adipocytes upon cytoad-
herence of iRBCs to CD36-expressing endothelial cells. However, 
failure to find schizonts outside of the adipose tissue microvascula-
ture combined with evidence of vascular permeability suggests that 
leakage of parasite material upon iRBC lysis is at least one mecha-
nism allowing parasite-induced adipocyte mTORC1 activation and 
increased leptin expression. Last, our data point to conservation of 
this phenomenon in P. falciparum–induced pediatric CM, based on 
the increase in leptin expression and phosphorylation of markers of 
mTORC1 activity in adipocytes in postmortem adipose samples. A 
schematic model of the cellular and molecular mechanisms by which 
specific parasite sequestration in WAT contributes to neuropathol-
ogy in CM is presented in Fig. 5.
The biological significance of CD36-mediated sequestration in 
neuropathology of both ECM and CM remains unclear. Human ge-
netic studies of CD36 deficiency have yielded conflicting results, 
associating with higher susceptibility to severe and/or CM in some 
studies (43, 44) but protection in others (45–47). CD36 is expressed 
only at very low levels in brain vasculature, and most P. falciparum 
isolates obtained from infected individuals bind to CD36 regardless 
of the severity of the infection (48). CD36 is highly expressed in tissues 
involved in fatty acid metabolism but is not up-regulated by proin-
flammatory cytokines associated with fatal malaria (49). In rodents, 
the finding that iRBC sequestration is dissociable from ECM pathology 
in CD36KO mice led to the conclusion that CD36-mediated seques-
tration in peripheral organs is not the basis of ECM (24), a pheno-
type confirmed here. Also consistent with this conclusion are reports 
that some nonsequestering PbK173 strains can still cause ECM (11, 50, 51).
The unexpected finding here that ECM susceptibility in CD36KO 
mice was a sexual dimorphic trait, while failure to support seques-
tration was not, complicates the interpretation that CD36-dependent 
sequestration is not the basis for ECM (11, 24). The finding is unex-
pected for two reasons: first, because ECM in WT mice occurs in 
both sexes without significant sexual dimorphism as reported here 
and elsewhere, and second, because although the original studies 
reported only female CD36KO mice (24, 25), another study reported 
a similar phenotype in CD36KO males with the caveat that all ani-
mals were lethally irradiated followed by bone marrow reconstitution 
to study the role of CD36 in hematopoietic versus nonhematopoietic 
cells (52).
With respect to the potential biological importance of sequestra-
tion in ECM, while it is possible that ECM is unrelated to CD36- 
dependent adipose sequestration, alternately, there may exist sexually 
dimorphic traits in female CD36KO mice that bypass a requirement 
for adipose sequestration specifically in this mutant. Differences in 
leptin signaling may be one such trait. In one report, CD36KO mice 
had ~2.5-fold elevated circulating leptin relative to WT mice due to 
loss of fatty acid uptake that normally inhibits leptin secretion by 
adipocytes, with females 40% higher than males (53). Here, we failed 
to see a significant increase in leptin in CD36KO mice but instead 
observed sexual dimorphism in baseline levels (reduced in females) 
and in the response to PbA infection (reduced at day 6 versus day 
0  in males). Changes in leptin sensitivity in the absence of CD36 
may also play a role (53–56). A number of other possibilities also 
exist, as CD36 is a major fatty acid translocase important in endo-
thelial cells and parenchymal cells particularly in adipose and muscle 
under conditions of low free fatty acids availability (57) and is also 
associated with insulin resistance and inflammation, in part, via its 
role in uptake of oxidized low-density lipoprotein (LDL) by macro-
phages. Unfortunately, although a number of additional phenotypes 
of CD36KO mice have been reported, including resistance to weight 
gain on high-fat diet and a reduction in another adipokine, adi-
ponectin, many studies only report the results of one sex, and thus, 
sexual dimorphisms are difficult to assess. At the molecular level, 
our study is hampered by the demonstration of reduced WAT 
mTORC1 activation only in male CD36KO mice. However, both 
the proposed trigger and functional result of mTORC1 activation, 
notably parasite sequestration and leptin production, respectively, 
are significantly reduced in CD36KO females and males relative to 
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infection in both sexes. Future studies are thus required to deter-
mine the mechanism of differential susceptibility to ECM between 
male and female CD36KO mice, which may shed further light on the 
uncertain role of CD36-mediated sequestration of WAT in cerebral 
complications of malarial infection. Notably, although the effect of 
rapamycin is also known to be affected by sex in other contexts, in 
our multiple experiments, we have not identified any sexual dimor-
phism in response to rapamycin treatment in terms of parasitemia 
and survival in WT mice.
Our data fail to support a role for increased circulating leptin 
in neuropathology of pediatric CM and thus merit caution with re-
gard to extrapolation from ECM to CM regarding the importance 
of WAT sequestration. Nonetheless, the conservation of iRBC se-
questration, mTORC1 activation, and increased local leptin expres-
sion in WAT in both humans and mice observed here remain 
suggestive of potential disease relevance, either functionally for 
the parasite or the host response or as a marker that could be ex-
ploited for therapeutic purposes. Species-specific differences in 
effects of iRBC WAT sequestration on circulating leptin could be 
related to the observation that WAT sequestration in humans 
appears to be limited to specific depots (2), while in mice sequestra-
tion in visceral fat was abundant and thus likely to contribute sig-
nificantly to circulating leptin levels. Because adipocytes are found 
in intimate contact with secondary lymphoid organs, vasculature, 
and neuro-adipose junctions (58), it is also possible that local leptin 
production could exert pathogenic effects in a paracrine manner, 
similar to the effects of perivascular WAT-derived adipokines on 
cardiovascular disease (59). Last, total leptin activity rather than its 
circulating levels alone might be the most relevant diagnostic factor 
in the pathology of human CM. The soluble leptin receptor reflects 
total activity of leptin, and hence, future studies may determine how 
the ratio between leptin and its soluble receptor predicts the patho-
genesis and outcome of human CM. Another adipokine, adiponec-
tin, has anti-inflammatory properties that could counterbalance the 
proinflammatory effects of leptin and influence the course of acute 
inflammation. Further research is warranted to elucidate a role for 
leptin/leptin receptor and leptin/adiponectin ratios in human CM 
pathology and their value as prognosis and/or diagnosis biomarkers. 
Moreover, if confirmed, the establishment of these ratios as patho-
genic factors in the development of CM could open previously un-
identified avenues for therapeutic interventions.
Notably, consistent with a potential role of ScWAT in disease 
progression, it has been shown in postmortem studies of CM cases 
that endothelial cells obtained from ScWAT are similar to endothe-
lial cells from cerebral vasculature in features relevant to CM pa-
thology such as tumor necrosis factor– (TNF-)–induced expression 
of adhesion molecules (8). Future experiments are thus required to 
uncover mechanisms of depot-specific WAT sequestration in hu-
mans and its relationship with disease severity.
WAT is the largest endocrine organ in the mammalian body, and 
this study suggests its importance in the pathogenic consequences 
of malarial infection. Furthermore, our data suggest targeting ScWAT 
sequestration and/or leptin production, for example, with mTORC1 
inhibitors such as the FDA-approved drug rapamycin, as potential 
new avenues for CM treatment. Last, the apparent specificity of 
ScWAT sequestration in CM patients and the relative accessibility 
of this tissue suggest potential diagnostic opportunities for the de-
termination of CM severity and prognosis.
Fig. 5. Model for the role of WAT iRBC sequestration in the neuropathology of CM. (A to C) CD36-dependent adhesion of infected RBCs to WAT endothelium (A) re-
sults in local vascular permeability potentially allowing contact between parasite material and adipocytes (B) and subsequent mTORC1 activation in these cells (C). 
(D) mTORC1 activation triggers the local expression and production of adipocyte-derived leptin. Circulating leptin increases upon infection and is required for full pene-
trance of neuropathology and mortality in the ECM model. Rapamycin treatment suppresses mTORC1 activation in WAT, reduces circulating leptin, and protects against 
neuropathology. In humans, although P. falciparum infection does not increase circulating leptin levels, iRBC sequestration, tissue leptin expression, and mTORC1 activity 









Mejia et al., Sci. Adv. 2021; 7 : eabe2484     24 March 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
9 of 11
MATERIALS AND METHODS
Human plasma and WAT samples
Archived samples in this study were part of larger studies assessing 
long-term neurocognitive outcomes, pathology, and inflammatory 
markers in children with CM and severe malarial anemia (SMA).
French, Senegalese, and Cambodian samples
P. falciparum–infected children aged less than 4 years were enrolled 
with a Blantyre coma score of <2 persisting for 30 min and/or at 
least two seizure episodes within 24 hours, with no other obvious 
causes of coma. Lumbar puncture was systematically performed to 
exclude meningitis. Children were given the appropriate treatment, 
as recommended by the local Ministry of Public Health. Controls 
consisted of plasma samples from healthy French Caucasian blood 
donors and malaria-negative Senegalese volunteers.
Uganda samples
Children with CM between 18 months and 12 years of age were 
enrolled. CM was defined as (i) coma (Blantyre Coma Scale score ≤ 2 in 
children ≤5 years or Glasgow Coma Scale score ≤ 8 in children 
>5 years), (ii) P. falciparum on blood smear, and (iii) no other known 
cause of coma (e.g., meningitis or encephalitis). Children with CM 
were managed according to the local Ministry of Health treatment 
guidelines at the time of the study. Children with CM were assessed 
for malaria retinopathy by indirect ophthalmoscopy. SMA was de-
fined as either a hemoglobin level of <5 g/dl or a hematocrit of <15%. 
Controls consisted of malaria-negative and asymptomatic malaria- 
positive Uganda samples.
Malawi samples
Children aged 6 months to 9 years who satisfied the clinical case 
definition of CM were enrolled in the study after consent was ob-
tained from a parent or guardian. CM was defined as a Blantyre 
Coma Score of ≤2, peripheral parasitemia with P. falciparum of any 
density, and no other discernible causes of coma.
Subcutaneous WAT tissue samples were cut from blocks gener-
ated as part of an existing project involving patients with pediatric 
CM from Malawi (15). Uninfected controls were obtained from dis-
carded tissue following vascular surgery.
Mice
All experimental mice were 8 to 10 weeks of age. WT female and male 
C57BL/6 (000664) mice on a C57BL/6 background were purchased 
from The Jackson Laboratory (Bar Harbor, ME). Male and female 
CD36KO mice on a C57BL/6 background were either purchased di-
rectly from The Jackson Laboratory (019006) or bred from hetero-
zygous animals in our facility. Transgenic UBC-GFP C57B/6 mice 
were obtained from the Institute of Cell Biology, University of Bern, 
Switzerland. Animals were housed four to five per cage and kept under 
standard laboratory conditions and allowed free access to water and food 
at all times. All experiments were performed with the approval of the 
appropriate institutional animal care and use committee associated with 
Harvard Medical Area, University of Glasgow, or University of Bern.
Parasites and infections
All four parasite strains used, including PbA, SMAC, SBP1 (34, 35), 
and PbK173 (36), were transgenic for constitutive expression of GFP- 
luciferase. In some sequestration experiments, mCherry-expressing 
PbA parasites (line 1804 mCherryHsp70 from the PbA GIMO mother 
line 1596cl1, Leiden) were used. For infections, cryopreserved para-
sites were thawed and passaged once in vivo before being used to 
infect experimental mice with 0.5 million parasitized RBCs per 
mouse by tail vein injection. When PbSMAC or SBP1 parasites 
were used for infections, their respective parental WT lines were used 
as controls. Parasites from peripheral blood were stained with SYTO16, 
and the percentage of infected cells was calculated by flow cytome-
try (60). Survival was followed for up to day 12.
Parasite sequestration
Infected mice were sacrificed on the indicated day and perfused with 
cold phosphate-buffered saline (PBS) intracardially. The organs were 
harvested, weighed, and homogenized in an equal volume per mil-
ligram of tissue of luciferase activity assay buffer (Invitrogen). Equal 
volumes were mixed with luciferin substrate and measured in a 96-well 
luminometer (Biotek Synergy 2). For in vivo imaging, infected mice 
were anesthetized and injected with luciferin. Luciferase activity 
was detected with IVIS Lumina In Vivo Imaging System.
Rapamycin treatment
Mice were treated with vehicle (5% Tween/5% polyethylene glycol 
400) or rapamycin (1 mg/kg) (LC Laboratories, Woburn, MA) once 
by intraperitoneal injection.
ELISA measurements
Mouse serum leptin was measured using a commercial enzyme-linked 
immunosorbent assay (ELISA) kit from Millipore (EZML-82 K; 0.2 to 
30 ng/ml), following the manufacturer’s instructions. Undiluted 
serum (5 l) was used per assay. Human leptin was measured using the 
Human Leptin Quantikine ELISA Kit from R&D Systems (DLP00, 
15.6 to 1000 pg/ml). Plasma (5 l) diluted 1:10 in dilution buffer pro-
vided by the manufacturer (50 l total) was used per reaction. 
Adiponectin and leptin were measured from supernatants of cultured 
differentiated primary adipocytes using the commercial mouse ELISA 
kits from R&D Systems (adiponectin, MRP300; 0.2 to 10 ng/ml).
Western blotting
NP-40 extracts of snap-frozen adipose tissues were separated by SDS–
polyacrylamide gel electrophoresis, transferred to polyvinylidene di-
fluoride membranes (Millipore), and stained with the following anti 
bodies (Cell Signaling Technology, Beverly, MA) at a 1:1000 dilution: 
rabbit (Rb) anti–-actin, Rb anti-total p70 S6K, and Rb anti–phospho-p70 
S6K (Thr389). After washing in PBS + Tween 20, membranes 
were incubated with horseradish peroxidase–conjugated antibodies 
1:5000 diluted in 5% skim milk. Detection was performed using the 
SuperSignal West Femto substrate (Thermo Fisher Scientific).
Microscopy
Sections were cut from paraffinized mouse organs from PBS-perfused 
animals or from human adipose samples and placed on slides. Antigen 
retrieval was performed by immersing the slides in 98.5°C prewarmed 
universal antigen retrieval solution (R&D Systems). After cooling in 
PBS, slides were permeabilized in 0.25% Triton X-100 in PBS, fol-
lowed by blocking in a 10% normal goat serum solution supple-
mented with 0.2 M glycine and 1% bovine serum albumin. Primary 
staining was performed with anti-leptin rabbit polyclonal (Abcam, 
ab16227) or anti–phospho-Ser235/235 S6 Alexa Fluor 488–conjugated 
rabbit monoclonal (Cell Signaling Technology, 4803) diluted 1:200 in 
blocking solution. Mouse and human WAT leptin and pS6 images 
were obtained in a Nikon TiE inverted microscope adapted with a 
Yokogawa CSU-X1 spinning disc processor and an air Plan Apo 20× 
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file was processed independently. No color or balance adjustment was 
performed on any image. For quantification, a threshold was defined 
using a positive and negative control. Then, the same threshold was 
used in a given cohort to measure fluorescence intensity and area of 
expression. To ensure unbiased quantification, the experiment was 
blinded as follows. After staining, slides were renumbered before 
acquisition and scanned by a different investigator. Image files were 
then quantified blindly by a third investigator before decoding.
ScWAT H&E images were acquired on a Zeiss Axio observer with 
a Plan apochromatic 20×/0.8 M27 [free working distance = 0.55] 
high-performance objective and an Axiocam 702 mono (D) high- 
performance monochromatic camera using Zen software. Images of 
mCherry-expressing PbA in iRBCs sequestered in microvasculature of 
UBC-GFP C57BL/6 pgWAT were acquired using a Zeiss spinning 
disc confocal microscope, with a Yokogawa CSU-X1 processor and 
a water immersion 63× objective. For dextran imaging, C57BL/6 
mice were intravenously injected with 200 l of fluorescein isothio-
cyanate (FITC)–dextran (5 mg/ml) (70 kDa), and the adipose tissue 
was imaged within 10 min after injection. Images were acquired 
using a Zeiss spinning disc confocal microscope, with a Yokogawa 
CSU-X1 processor and a water immersion 63× objective.
In vitro experiments
Primary mouse preadipocytes were differentiated as follows: After 
confluence, cells were incubated with a cocktail containing dexameth-
asone (2.5 M), 3-isobutyl-1-methylantine (0.5 mM), and insulin 
(10 g/ml) for 2 days. The medium was then changed every 2 days 
until complete cell bubbling was observed. Differentiated prima-
ry adipocytes were then infected with lentivirus expressing an 
shRNA targeting the mTORC1 inhibitory protein TSC2 or a scram-
bled shRNA. Two days after infection, the medium was removed for 
leptin and adiponectin detection by ELISA, and cells were lysed 
using TRIzol for reverse transcription quantitative polymerase chain 
reaction (RT-qPCR) analysis of leptin and adiponectin transcripts.
Gene expression
Total RNA was extracted from cultured cells using TRIzol (Invitrogen). 
Hexamer-primed complementary DNA (cDNA) was synthesized with 
the Verso cDNA Kit (Thermo Fisher Scientific) according to the man-
ufacturer’s instructions. Quantitative real-time polymerase chain 
reaction was performed with MyIQ (Bio-Rad) using SYBR Green. 
Relative expression was calculated with the Ct method. cDNA 
expression of each sample was standardized to RPLA13. Each sam-
ple was tested in duplicate at least twice. Primer sequences used are 
as follows: leptin, 5′-GAGACCCCTGTGTCGGTTC-3′ (forward) 
and 5′-CTGCGTGTGTGAAATGTCATTG-3′ (reverse); adiponectin, 
5′-TGTTCCTCTTAATCCTGCCCA-3′ (forward) and 5′-CCAA-
CCTGCACAAGTTCCCTT-3′ (reverse).
Statistics
Data are expressed as mean ± SD. Statistical analyses were performed 
in GraphPad Prism, and a P value of less than 0.05 was considered 
significant.
View/request a protocol for this paper from Bio-protocol.
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